Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making RESEARCH TRIANGLE PARK, N.C.--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a funded research collaboration [...]

PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing

Expands access to streamlined genomic data analysis across the PacBio partner ecosystem MENLO PARK, Calif. & BERLIN -- PacBio (NASDAQ: PACB), a premier developer of sequencing solutions, and Lucid Genomics GmbH, a provider of cutting-edge bioinformatics software for clinical and research genomics, today announced that Lucid Genomics has joined the PacBio Compatible partner program as [...]

MilliporeSigma Launches First Bio-Based Solvent Portfolio for HPLC

MilliporeSigma introduces the first bio-based solvent portfolio for HPLC – renewable feedstocks, proven chromatography performance and lower CO2e. Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials Drop-in replacements preserve established chromatography performance Supports progress toward sustainability targets by lowering product-related greenhouse gas emissions Burlington, Massachusetts, United States of America -- MilliporeSigma, the [...]

Axion BioSystems and Agilent Technologies Resolve Litigation

ATLANTA, GA -- Axion BioSystems, Inc., a leading provider of live-cell analysis technologies, today announced that Agilent Technologies, Inc. and Axion BioSystems have fully resolved the issues in the two lawsuits between them, pending in the United States District Court for the District of Delaware, pursuant to the terms of a confidential settlement agreement. Neither [...]

ENPICOM Joins the Pistoia Alliance

Membership deepens ENPICOM's commitment to advance AI and autonomous agent infrastructure for life sciences R&D ‘s-Hertogenbosch, The Netherlands – Life Science Newswire – ENPICOM, an innovative bioinformatics and AI company, today announced that it has joined the Pistoia Alliance, the global not-for-profit organization working to lower barriers to innovation in life science and healthcare R&D. [...]

Claret Bioscience® and New England Biolabs® Announce Co-Promotion Collaboration for Methylation and Fragmentomics Research-Use Workflows

Claret Bioscience and New England Biolabs (NEB® ) have entered into a co-promotion agreement to support researchers using SRSLY® MethylPlus in combination with the NEBNext® EM-seq™ v2 Conversion Module. SRSLY MethylPlus and SRSLY Uracil+ products are designed to integrate with enzymatic methyl-conversion workflows, enabling high-quality library preparation for methylation profiling and fragmentomics research. The collaboration [...]

ViewsML Secures Funding to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform

VANCOUVER, British Columbia -- ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M seed funding round led by Wittington Ventures. Additionally, new investors Continuum Health Ventures and Mayo Clinic contributed alongside repeat investors RiSC Capital, Debiopharm, [...]

Labbit Goes All-In on LIMS Platform, Retires Semaphore Solutions Brand

After a decade of implementing laboratory systems for regulated labs, company consolidates under the Labbit name to focus entirely on its modern LIMS platform VANCOUVER, BC - Labbit, a laboratory information management system (LIMS) built for regulated laboratories running complex workflows, today announced it has retired the Semaphore Solutions brand and consolidated operations under the [...]

RareCyte Expands Clinical-Scale Spatial Proteomics Portfolio with New Orion Systems and Leadership Appointment

Orion HT and Orion LE extend the Orion platform from assay development through clinical trials, backed by an expanding biomarker reagent portfolio and commercial leadership focused on global growth SEATTLE -- RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of [...]

Integrated DNA Technologies Expands Coralville Manufacturing Footprint to Support Growing Global Demand for MRD Solutions

Expanded footprint delivers speed, scale and customization minimal residual disease (MRD) innovators need without compromising quality Increased production capacity leverages IDT’s highly specialized, high-throughput manufacturing platform  CORALVILLE, Iowa —Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, today announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a [...]

Access IBO on Knowledge Center